Please use this identifier to cite or link to this item:
|Title:||Peroxisome proliferator-activated receptor-γ and the endothelium : implications in cardiovascular disease|
|Authors:||Magri, Caroline Jane|
Xuereb, Robert G.
Cardiovascular system -- Diseases
Peroxisomes -- Receptors
|Publisher:||Taylor & Francis|
|Citation:||Magri, C. J., Gatt, N., Xuereb, R. G., & Fava, S. (2011). Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease. Expert Review of Cardiovascular Therapy, 9(10), 1279-1294.|
|Abstract:||Peroxisome proliferator-activated receptors-γ (PPARγs) are ligand-activated transcription factors that play a crucial regulatory role in the transcription of a large number of genes involved in lipid metabolism and inflammation. In addition to physiological ligands, synthetic ligands (the thiazoledinediones) have been developed. In spite of the much publicized adverse cardiovascular effects of one such thiazoledinedione (rosiglitazone), PPARγ activation may have beneficial cardiovascular effects. In this article we review the effects of PPARγ activation on the endothelium with special emphasis on the possible implications in cardiovascular disease. We discuss its possible role in inflammation, vasomotor function, thrombosis, angiogenesis, vascular aging and vascular rhythm. We also briefly review the clinical implications of these lines of research.|
|Appears in Collections:||Scholarly Works - FacM&SMed|
Scholarly Works - FacM&SPat
Files in This Item:
|1.69 MB||Adobe PDF||View/Open Request a copy|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.